Researchers at University of Waterloo have developed an artificial intelligence system, designed in combination with new MRI technology, to identify patients who might benefit from neoadjuvant chemotherapy for breast cancer.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.